More children vaccinated against mumps, measles, rubella and HPV The percentage of newborns participating in the immunisation programme targeting mumps, measles and rubella rose slightly over the past year.
Cost-effective risk assessment of nanomaterials may be feasible Companies, authorities and scientists can save time, money and test animals in the risk assessment of nanomaterials by using available data.